Table 5. Favorable tumor immune microenvironment according to the literature.
| Component | Description |
|---|---|
| PD-L1 expression | High PD-L1 expression favorable for immunotherapy |
| TIL | High TIL density favorable for immunotherapy |
| CD 8 cell | Density of CD103+ CD8+ cells in tumor tissues showed significant association with improved progression-free survival in patients receiving immunotherapy |
| T effector cell | T effector cells play a central role in cytotoxic cell death; however, Treg cells are associated with immune evasion of tumor cells |
| T reg | Teff/Treg cell ratio showed potential prognostic and predictive values in many tumor types |
| Plasma cell | Plasma cell signatures were also reported to have predictive value for improved overall survival in non-small cell lung cancer patients receiving immunotherapy |
PD-L1, programmed death-ligand 1; TIL, tumor-infiltrating lymphocytes.